Short US marketUS cases climbed by 13,000 to 68,000 cases (stats from worldometer site) already and it seems like the rally 2 days ago just took a small turn downwards. I still think it will continue heading downwards till either vaccine is released or when the numbers are better controlled. Because looking at the growth rate, it doesn't look like its slowing down and many countries have started partial shutdowns and I think the impact on their economy will be huge but the real effect on the economy can only be seen at a later stage.
Coronavirusstocks
COVID-19 : No Recovery till NowNumber of death continue increasing , this is very serious case.
Plaese follow these steps to avoid effect.
ThankYou
Long $SPCE after MS changes viewMorgan Stanley upgrading Virgin Galactic back to overweight from equal-weight.
Will it go back to 40? We don't know?
Has this market Bottomed? We don't know?
Today is a more positive day Italian index is +7 on the news they might have passed the peak.
Oil company Shell is up double digits today as well.
so there is hope. And man will once more want to go to space.
TTD.V -- Medical supplies 3D printing services; CoronaVirus hypeTTD.V is cheap at $3.5M mkt cap and is joining the CoronaVirus hype train with today's news:
Tinkerine Studios in Collaboration with Medical Community produces critically needed 3D Printed Products for COVID-19
----------------------------------------------------------------------------------------------------------------------------------------------------
March 23, 2020 – TheNewswire - Tinkerine™ Studios Ltd. (TSXV:TTD) ("Tinkerine" or the "Company") announces that with extensive input from medical doctors, general practitioners, emergency responders, nurses, and pharmacists, the Company’s Applied Design Staff has initiated the design and 3D printing of the following devices:
1.Face Shield
--Tinkerine now has a working prototype that was printed using its DittoPro 3D printers. The Face Shield will be presented immediately to regional health authorities. Tinkerine’s Face Shield has received strong input from members of the health community to ensure proper fit and protection for users. The face shield is a prototype design;
2.Ventilator 4-way Splitter
--Tinkerine and outside parties are currently designing a 4-way splitter that can be used in emergency situations to provide additional capacity for ventilators. Considerations include cross contamination and a one-way check valve to ensure safety. The 4-way splitter is in early stage and is a prototype design;
3.Medical Use Goggles
--Input from regional health members resulted in recognizing current and future demand for medical goggles for use in hospitals and other medical facilities. Tinkerine is determining needs based on input from medical professionals and will initiate design ASAP.
Tinkerine is also reaching out to its community of teachers and educational professionals to utilize their school districts and post-secondary institutions’ Tinkerine 3D printers. Tinkerine products are in use in 45% of all school districts in its home province of British Columbia. The Company is getting assistance from its Education Advisory Board and Teacher User Group, to create a collaborative pool of 3D Printers to produce greater volumes of medical products and supplies that are in scarce supply. Through this collaboration Tinkerine is working to deploy between 500-1000 additional 3D printers in order to address the COVID-19 healthcare crisis. In the meantime, Tinkerine has initiated discussions with National Resource Council Canada about additional expansion opportunities.
The Tinkerine team wants to thank all of the participating healthcare professionals for their assistance and would like to encourage additional members of the medical community to contact our offices about critical products that may be produced using 3D printers. We also want to express our appreciation to all medical and emergency staff for their tireless and selfless efforts to keep us all safe and healthy.
how traders be looking at the #coronavirus #covid19 chartwhat do you think, will it push higher or will it start lowering?
The Corona Virus Conspiracy ------ WAKE UP IT'S ALL PLANNED MartyBoots here , I've been trading the markets for 13 years and I have see this Panic before
What is unusual is that the Corona virus could have actually been used to manipulate the masses and even other countries
Who needs real war when you can just create a deadly virus
Anyway let me know in the comments what you guys think
Please like the Video to help my work
This is not my normal video , I just thought I would put it out there because there are a few very fishy elements to this situation , this is also evident in the charts
AGN.C -- Coronavirus Treatment Spec; Phase 2 Clinical Trial newsAnother CoronaVirus spec play. Pulled back from recent highs and trading in the support band, for now. I bought in at .20 - .21 today. $18M mkt cap. 90M float. Could see a nice run on today's news:
Algernon to Support Planned Phase 2 Trial of Ifenprodil for Coronavirus
VANCOUVER, British Columbia, March 19, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that Novotech, a leading Asia-Pacific clinical research organization (CRO), has identified physicians in South Korea who have agreed to conduct an investigator initiated phase 2 clinical trial of Ifenprodil for coronavirus patients.
The investigators were identified after Algernon retained Novotech to conduct a feasibility study in South Korea. Novotech was asked to advise on the most efficient regulatory approach to initiating a phase 2 clinical trial for Ifenprodil for COVID-19 and to also help identify potential investigators.
Ifenprodil is an already approved drug in South Korea and Japan for certain neurological conditions with a known safety history. Algernon has been investigating Ifenprodil under its re-purposed drug program and has appointed Novotech as the lead CRO for its upcoming idiopathic pulmonary fibrosis (IPF) and chronic cough phase 2 clinical trial to be conducted in Australia.
The Company is in the process of refining the protocol for the phase 2 coronavirus study after receiving input from the investigators, and is working with Novotech to provide the necessary information and support in order to assist with the study’s approval. The study approval process may be expedited due to the current global health crisis.
The Company will release more information about the planned phase 2 coronavirus study shortly.
The decision to retain Novotech to conduct a feasibility study was made after a recent independent study found that Ifenprodil significantly reduced acute lung injury (ALI) and improved survivability in an animal study with Asian H5N1 infected mice by 40%. Asian H5N1 is the most lethal form of influenza known to date with an over 50% mortality rate. The drug was also previously shown in a separate study to prolong survival under anoxic (low oxygen) conditions, as might occur in patients with severely impaired lung function.
“This independent study data, along with the data generated from the Company’s animal studies on IPF and chronic cough, have supported the Company’s recent new COVID-19 and acute lung injury clinical program,” said Christopher J. Moreau CEO of Algernon Pharmaceuticals.
LBL.V -- Stem cell based CoronaVirus treatment; VOLUME!LBL.V is hitting highest volume on TSX-V today. Very similar setup to VXL.V from last week, just before it made the big move from .14 to .325 but cheaper and much better financials. Cash flow positive. $8.4M market cap. 93M shares out.
See the most recent news release with regards to positive outcomes in applying their technology to treat the Coronavirus patients in China:
"Recently published results from an investigator-initiated clinical study conducted in China which reported that allogeneic mesenchymal stem cells (MSCs) cured or significantly improved functional outcomes in all seven treated patients with severe COVID-19 pneumonia."
Google "Lattice Biologics to Evaluate Anti-Inflammatory Stem Cell Therapy Treatment of COVID-19 Lung Disease"
Coronavirus: Flattening the CurveI'm sure most of us have seen a chart similar to this at some point within the last few days, but it bears repeating in light of a lack of serious analysis and explanation in most media outlets (who are more focused on politics and opinions instead of facts). This failure on the part of the media has led to generating an unnecessary amount of fear. In large groups of people, emotions such as fear tend to win out over logic, as any seasoned trader should know.
A lot of people are panicking because they believe that everything shutting down must mean that this virus is exceptionally dangerous and deadly. This appears not to be the case. Instead, everything is shutting down in order to slow down its spread to a more manageable level. This is a normal epidemiological response to a rapidly spreading infection. COVID-19 is a highly contagious virus and it is likely that everybody will catch it at some point in the next several months. This is probably unavoidable. However, if the released data are accurate, it seems be causing serious problems for only the elderly and people with compromised immune systems.
So why shut everything down?
In the chart, everybody gets infected in the end no matter what, but if everyone gets infected too fast, there will be more of those serious cases than hospitals can handle. There won't be enough hospital beds, doctors, nurses, etc. to be able to keep up with the number of people that need help. This is represented by the red curve. You can see how the red curve accelerates upwards so fast that it quickly exceeds the total capacity of the local healthcare system represented by the dotted line.
Instead, if everything is shut down for several weeks, you slow the rate of the infection spreading by preventing large crowds from mingling. In the end, everyone still gets infected, but it takes place more slowly. This means that the serious cases still happen but at a rate that is manageable by the hospitals. Stretching out the infection to a longer period of time makes sure there are always enough hospital beds to keep up with the most serious cases. This is represented by the blue curve which never surpasses the capacity of the healthcare system but takes more time to play out.
Keep this in mind when you see people panicking and hoarding a lifetime's supply of toilet paper.
Don't let fear beat logic.
My name is Yrat and thank you for coming to my TED talk.
What will happen to cryptomarkets next monthsObserving the rapidly developing market situation related mainly to the coranovirus pandemic, I have general thoughts about what will happen in the near future.
We are currently facing a major crisis that will not end as soon as in 2008 due to the fact that the situation is much more complicated than the banking crisis in 2008.
I believe that the markets will fall longer than in 2008 and there will be no sharp rebound. I bet that the markets will be looking for the bottom in this unpredictable situation for a long time and the injection of cash into the economy as in 2008 will not solve the situation because we are dealing not only with a financial but also a social crisis.
It is said that bitcoin will be a safe haven because it was created in response to the financial crisis in 2008. However, I believe that this crisis is much more serious than in 2008, so this simple comparison will not take place here, and cash will remain the most valuable thing during the crisis.
Probably, we are facing the most serious crisis, perhaps in line with the crisis of the 1930s.
Good luck and be safe!
Fed`s surprise, coronavirus chronicles, ADP numbersThe main event of yesterday was the Fed’s decision to urgently reduce the rate by 0.5%. The central bank did not wait on March 18 and caught many by surprise. The reaction of the financial markets as a whole seemed logical: the US stock market went up, the dollar was falling, gold was growing. The whole question is whether these trends will continue. We practically do not doubt gold and put on its further growth. The US stock market may well grow by a further wave of optimism by a few percents. But the closer he gets closer to historical highs, the stronger will be our desire to sell. The dollar will be able to take revenge on Friday, but more on that below.
In the meantime, we traditionally continue to review the news from epidemic fronts. The epidemic in China has virtually disappeared (130 new cases), but in the world, everything is in full swing (almost 2000 new cases per day).
G7 countries, meanwhile, held an emergency meeting at which they firmly decided to confront the economic consequences of the epidemic.
Inspired by this news, as well as information about a possible massive easing of monetary policies around the world (the Central Bank of Australia also lowered the rate yesterday and thereby confirmed reasonable expectations), investors again breathed a sigh of relief and rushed to buy cheaper assets. We traditionally do not share this optimism and consider it clearly premature. The consequences are just beginning to manifest. So in the next month, depressing news will be enough.
On the foreign exchange market yesterday there was a certain return of common sense. In terms of the fact that the euro stopped growing at the end of the day (even against the background of information about the Fed’s rate reduction of 0.5%), the pound seemed to have found some ground under its feet. All the attention of traders is focused on the first rand of trade negotiations between the EU and the UK. The results will not be earlier than Thursday. So far, we generally consider all this to be nothing more than noise, which can only give the best entry points. Really, nothing will be solved now, which means you should not worry about anything. Recall that our position on the pound is medium-term purchases. Justification - The EU and the UK will eventually be able to agree again.
As for the euro, it seems that there was a less clear explanation for its growth in recent days. In addition to the classic for almost any strong movement of triggering stop loss and buy-stop, analysts call the curtailment of the trade due to the coronavirus epidemic as the main reason for the sharp strengthening of the euro against the dollar. For those who are not in the know, we explain that the ultra-low rates in the Eurozone made it possible to borrow money there and invest them in markets with higher returns (for example, the USA). Which naturally led to a depreciation of the euro. Curtailment is marked by opposite trends, respectively, the euro strengthened. Rumors that the Fed will sharply reduce the rate in March and may reduce the rate even later in 2020 provoked the start of the process of curtailing the trade, which was especially clearly reflected in the EURUSD pair.
News about the epidemic has recently monopolized the information space so much that it’s easy to miss important news that does not have the word coronavirus or something like that in the headline.
We mean that on Friday statistics on the US labor market will be published. This news is traditionally one of the main ones for financial markets. Considering how sensitive markets are now to any deviations from the norm, these data are of increased importance. But the numbers on the NFP will be published only on Friday, but for now, today we are waiting for data from ADP.